Peer-reviewedCC BYJournal of Diabetes
Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials
- 1Department of Endocrinology and Metabolism Peking University People's Hospital Beijing China
Related
- Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study
- Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
- Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
- De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
- Beyond medication: rethinking postpartum obesity management in the era of increasing GLP-1 receptor agonist use
BibTeX
@article{yang2026baseline,
title = {{Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials}},
author = {Wenjia Yang and Wei Zhao and Xiaoling Cai and Linong Ji},
journal = {Journal of Diabetes},
year = {2026},
month = oct,
doi = {10.1111/1753-0407.70283},
url = {https://doi.org/10.1111/1753-0407.70283},
note = {CC BY},
}
RIS
TY - JOUR
TI - Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials
AU - Wenjia Yang
AU - Wei Zhao
AU - Xiaoling Cai
AU - Linong Ji
PY - 2026
DA - 2026/10/27
JO - Journal of Diabetes
DO - 10.1111/1753-0407.70283
UR - https://doi.org/10.1111/1753-0407.70283
SN - 1753-0407
SN - 1753-0393
ER -